Yongjun Wang Selected Research

C-Reactive Protein

3/2024	Plasma sACE-2 and risk of recurrent stroke: a nested case-control analysis.
12/2023	Association between clonal hematopoiesis-related gene mutations and unfavorable functional outcome in patients with large-artery atherosclerotic stroke.
9/2023	High-Sensitivity C-reactive Protein and Intracranial Arterial Stenosis Predicted Recurrent Stroke and Dependence or Death in Minor Stroke or Transient Ischemic Attack.
6/2023	Elevated hs-CRP and Symptomatic Intracranial/Extracranial Artery Stenosis Predict Stroke Recurrence after Acute Ischemic Stroke or TIA.
3/2023	High-Sensitivity C-Reactive Protein Modifies P-Wave Terminal Force in Lead V1-Associated Prognosis in Acute Ischemic Stroke or TIA Patients.
2/2023	Predictive Role of hsCRP in Recurrent Stroke Differed According to Severity of Cerebrovascular Disease: Analysis from a Prospective Cohort Study.
1/2023	Colchicine in High-risk Patients with Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3): Rationale and design of a multicenter randomized placebo-controlled trial.
1/2023	Somatic mutation contributing to clonal haematopoiesis is a risk factor of recurrent stroke in first-ever acute ischaemic stroke: a prospective cohort study.
1/2023	Mediation of Systemic Inflammation on Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke.
11/2022	Effect of different doses of colchicine on high sensitivity C-reactive protein in patients with acute minor stroke or transient ischemic attack: A pilot randomized controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yongjun Wang Research Topics

Disease

337	Stroke (Strokes) 10/2024 - 01/2006
268	Ischemic Stroke 01/2025 - 01/2006
120	Transient Ischemic Attack 03/2024 - 05/2008
108	Neoplasms (Cancer) 05/2024 - 05/2008
50	Hemorrhage 05/2024 - 06/2006
48	Inflammation (Inflammations) 10/2024 - 01/2006
36	Pathologic Constriction (Stenosis) 12/2023 - 01/2006
32	Atherosclerosis 02/2024 - 09/2008
28	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 10/2013
22	Insulin Resistance 02/2024 - 03/2005
21	Diabetes Mellitus 12/2022 - 05/2008
20	Atrial Fibrillation 12/2023 - 01/2013
19	Cerebral Hemorrhage 12/2023 - 05/2008
18	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2015
15	Infarction (Infarctions) 10/2024 - 05/2008
15	Cognitive Dysfunction 01/2024 - 09/2012
15	Spinal Cord Injuries (Spinal Cord Injury) 12/2023 - 12/2010
14	Hypertension (High Blood Pressure) 03/2024 - 05/2009
12	Myocardial Infarction 02/2024 - 01/2015
12	Brain Ischemia (Cerebral Ischemia) 12/2023 - 12/2012
10	Osteosarcoma (Osteogenic Sarcoma) 03/2024 - 07/2015
10	Rheumatoid Arthritis 10/2023 - 08/2014
10	Type 2 Diabetes Mellitus (MODY) 10/2023 - 01/2014
10	Breast Neoplasms (Breast Cancer) 01/2023 - 08/2015
10	Hyperglycemia 01/2022 - 01/2015
10	Infections 05/2021 - 07/2004
9	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2023 - 11/2014
9	Obesity 10/2023 - 01/2009
9	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 12/2008
8	Embolic Stroke 03/2024 - 01/2013
8	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023 - 03/2015
8	Pain (Aches) 11/2023 - 02/2011
8	Thrombosis (Thrombus) 07/2023 - 01/2014
8	Prediabetic State (Prediabetes) 01/2023 - 03/2012
8	Hematoma 11/2022 - 12/2011
8	Arthritis (Polyarthritis) 01/2022 - 03/2016
7	Ischemia 12/2023 - 05/2008
7	Crohn Disease (Crohn's Disease) 09/2023 - 08/2014
7	Cerebral Infarction 04/2023 - 05/2008
7	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 01/2018
7	Carcinoma (Carcinomatosis) 01/2022 - 11/2010
7	Peripheral Nerve Injuries 08/2019 - 09/2011
6	Hemorrhagic Stroke 05/2024 - 07/2013
6	Atherosclerotic Plaque (Atheroma) 12/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

91	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2024 - 01/2006
79	Clopidogrel (Plavix)FDA Link 05/2024 - 09/2010
54	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 05/2008
44	TicagrelorIBA 05/2024 - 07/2016
41	Biomarkers (Surrogate Marker)IBA 02/2024 - 11/2010
36	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2024 - 02/2009
30	Cytochrome P-450 CYP2C19IBA 05/2024 - 07/2016
30	C-Reactive ProteinIBA 03/2024 - 01/2013
26	oxidized low density lipoproteinIBA 03/2024 - 06/2011
25	Proteins (Proteins, Gene)FDA Link 02/2024 - 04/2009
25	LipidsIBA 07/2023 - 04/2009
21	ProdrugsIBA 01/2023 - 11/2015
20	Triglycerides (Triacylglycerol)IBA 02/2024 - 01/2006
19	Liposomes (Liposome)IBA 05/2023 - 05/2016
17	danaparoid (Orgaran)FDA Link 05/2023 - 07/2010
16	LDL CholesterolIBA 03/2024 - 11/2014
15	Interleukin-6 (Interleukin 6)IBA 10/2024 - 02/2014
15	CholesterolIBA 03/2024 - 09/2008
14	Paclitaxel (Taxol)FDA LinkGeneric 05/2024 - 04/2013
14	Hemoglobins (Hemoglobin)IBA 01/2024 - 02/2014
14	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 05/2008
13	Therapeutic UsesIBA 01/2025 - 05/2008
13	AlbuminsIBA 04/2024 - 03/2015
13	Antihypertensive Agents (Antihypertensives)IBA 02/2024 - 05/2008
13	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2014
13	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 06/2012
13	CytokinesIBA 03/2022 - 01/2006
13	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2012
11	HomocysteineIBA 02/2024 - 07/2010
11	LigandsIBA 01/2021 - 07/2010
10	Uric Acid (Urate)IBA 12/2023 - 03/2014
9	Insulin (Novolin)FDA Link 12/2023 - 03/2005
9	CreatinineIBA 12/2023 - 01/2014
9	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 05/2023 - 09/2010
8	MicroRNAs (MicroRNA)IBA 12/2023 - 09/2011
8	Messenger RNA (mRNA)IBA 09/2020 - 11/2010
7	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 05/2024 - 12/2012
7	HDL CholesterolIBA 03/2024 - 11/2014
7	AnticoagulantsIBA 02/2023 - 05/2008
7	RNA (Ribonucleic Acid)IBA 01/2023 - 09/2013
7	Long Noncoding RNAIBA 01/2023 - 09/2017
7	Peptides (Polypeptides)IBA 01/2022 - 01/2013
7	CateninsIBA 01/2022 - 08/2012
7	DisulfidesIBA 07/2021 - 01/2016
6	EnzymesIBA 10/2024 - 11/2009
6	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 05/2008
6	Macrophage Migration-Inhibitory FactorsIBA 12/2023 - 01/2017
6	AntigensIBA 12/2023 - 09/2013

Therapy/Procedure

197	Therapeutics 01/2025 - 05/2008
40	Secondary Prevention 02/2024 - 01/2006
26	Thrombectomy 03/2024 - 06/2016
17	Drug Therapy (Chemotherapy) 01/2023 - 05/2008
12	Stents 02/2023 - 01/2006
8	Length of Stay 01/2019 - 12/2011
7	Precision Medicine 07/2023 - 12/2014
6	Immunotherapy 12/2023 - 09/2021